Value Added Technology Co., Ltd. (KOSDAQ:043150)
23,500
+50 (0.21%)
Sep 19, 2025, 3:30 PM KST
Value Added Technology Revenue
Value Added Technology had revenue of 110.62B KRW in the quarter ending June 30, 2025, with 8.47% growth. This brings the company's revenue in the last twelve months to 400.92B, up 3.26% year-over-year. In the year 2024, Value Added Technology had annual revenue of 385.19B with 0.06% growth.
Revenue (ttm)
400.92B
Revenue Growth
+3.26%
P/S Ratio
0.87
Revenue / Employee
1.31B
Employees
307
Market Cap
349.08B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 385.19B | 249.51M | 0.06% |
Dec 31, 2023 | 384.95B | -10.11B | -2.56% |
Dec 31, 2022 | 395.06B | 56.08B | 16.54% |
Dec 31, 2021 | 338.98B | 94.67B | 38.75% |
Dec 31, 2020 | 244.31B | -27.39B | -10.08% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 5.18B |
PharmaResearch | 449.81B |
ABL Bio | 94.93B |